In a significant move to enhance the safety and readiness of China’s armed forces, Xi Jinping, chairman of the Central Military Commission (CMC), has signed an order to release revised guidelines on enforcing drug administration laws within the military.
The new regulations aim to update and strengthen the management of pharmaceuticals used by military personnel, ensuring that the use, distribution, and oversight of drugs align with current legal standards and best practices.
The guidelines were jointly published by China’s State Council and the CMC, indicating a collaborative effort between the nation’s highest administrative body and its military leadership to address this critical aspect of military health and preparedness.
Premier Li Qiang also signed a State Council decree to release the document, underscoring the importance of the revised regulations at the highest levels of government.
This initiative reflects China’s commitment to modernizing its military operations and maintaining the well-being of its service members, as it continues to play a prominent role on the global stage.
